Final Takeaways: Optimum’s 12th Annual Healthcare Investor Conference 2020
2021: Priorities for European Pharma & What does the investment landscape look like post Covid-19?
2021: Priorities for European Pharma & What does the investment landscape look like post Covid-19?
This year, in collaboration with Dechert, we held a virtual version of our leading Annual Healthcare Investor Conference on the 8th of October. The 12th event discussed how life sciences innovation is driving change – from the myriad international efforts against Covid-19 to how we communicate with the investment community. The virtue of virtual was […]
– Future of healthcare conference in partnership with Dechert LLP goes virtual – Panellists include eminent leaders from healthcare industry and investment community LONDON, Oct. 5, 2020 /PRNewswire/ — Optimum Strategic Communications (Optimum), the international strategic healthcare communications firm, will be hosting its 12th Annual Healthcare Investor Conference virtually, in partnership with Dechert LLP, on Thursday, 8 October 2020. In an unprecedented time for […]
Phase 2 data from Arix portfolio company Amplyx and why anti-infectives are especially important now during the pandemic.
As many countries continue to pass the peak of COVID-19, Masters Speciality Pharma’s Head of Licensing, Sid Masters believes now is a good time to reflect on the challenges, successes and response of the pharmaceutical industry during the pandemic. Sid writes: Over the past few months we have seen Covid-19 wreak havoc by crippling our […]